We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
Cap. Flow
+$518M
Cap. Flow %
0.87%
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$68M
2
TFC icon
Truist Financial
TFC
+$55.9M
3
NOW icon
ServiceNow
NOW
+$33.3M
4
UBER icon
Uber
UBER
+$21.4M
5
LVS icon
Las Vegas Sands
LVS
+$15.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$119M
2
STI
SunTrust Banks, Inc.
STI
+$55.9M
3
AAPL icon
Apple
AAPL
+$48.3M
4
TIP icon
iShares TIPS Bond ETF
TIP
+$22M
5
VIAB
Viacom Inc. Class B
VIAB
+$16.4M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Financials 15.53%
3 Healthcare 13.38%
4 Consumer Discretionary 10.07%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NATR icon
2851
Nature's Sunshine
NATR
$363M
$123K ﹤0.01%
13,803
+88
+0.6% +$826
RNET
2852
DELISTED
RigNet, Inc.
RNET
$123K ﹤0.01%
18,690
+215
+1% +$1.29K
CVIA
2853
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$121K ﹤0.01%
59,292
+508
+0.9% +$820
MBIO icon
2854
Mustang Bio
MBIO
$4.45M
$120K ﹤0.01%
39
+1
+3% +$2.29K
RLH
2855
DELISTED
Red Lions Hotel Corporation
RLH
$120K ﹤0.01%
32,168
+125
+0.4% +$583
PYX
2856
DELISTED
Pyxus International, Inc.
PYX
$120K ﹤0.01%
13,368
+390
+3% +$3.77K
GDP
2857
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$119K ﹤0.01%
11,827
+73
+0.6% +$709
BXG
2858
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
$117K ﹤0.01%
11,324
+160
+1% +$1.57K
NMR icon
2859
Nomura Holdings
NMR
$28.6B
$115K ﹤0.01%
22,293
-2,153
-9% -$10.4K
PTGX icon
2860
Protagonist Therapeutics
PTGX
$8.6B
$115K ﹤0.01%
16,291
+751
+5% +$7.46K
SLDB icon
2861
Solid Biosciences
SLDB
$840M
$115K ﹤0.01%
1,727
+138
+9% +$15.2K
GNE icon
2862
Genie Energy
GNE
$373M
$114K ﹤0.01%
14,800
+200
+1% +$1.57K
GSIT icon
2863
GSI Technology
GSIT
$257M
$112K ﹤0.01%
15,846
+479
+3% +$3.62K
KALA icon
2864
KALA BIO
KALA
$14.8M
$112K ﹤0.01%
12
+1
+9% +$9.66K
SBOW
2865
DELISTED
SilverBow Resources, Inc.
SBOW
$111K ﹤0.01%
11,186
+37
+0.3% +$350
KNTK icon
2866
Kinetik
KNTK
$3.6B
$108K ﹤0.01%
3,786
+140
+4% +$3.22K
OPRX icon
2867
OptimizeRx
OPRX
$130M
$108K ﹤0.01%
+10,561
New +$120K
ACRS icon
2868
Aclaris Therapeutics
ACRS
$821M
$106K ﹤0.01%
55,994
+1,935
+4% +$3.21K
LJPC
2869
DELISTED
La Jolla Pharmaceutical Company
LJPC
$105K ﹤0.01%
26,817
+48
+0.2% +$283
TCS
2870
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$104K ﹤0.01%
1,643
+7
+0.4% +$444
ASNA
2871
DELISTED
Ascena Retail Group, Inc.
ASNA
$103K ﹤0.01%
13,483
+16
+0.1% +$131
NEXT icon
2872
NextDecade
NEXT
$1.78B
$101K ﹤0.01%
16,405
+300
+2% +$1.87K
KDNY
2873
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$101K ﹤0.01%
17,195
+17
+0.1% +$92
VBIV
2874
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$98K ﹤0.01%
2,366
+244
+11% +$5.34K
YARW
2875
Yarrow Bioscience, Inc. Common Stock
YARW
$25.5M
$95K ﹤0.01%
6
– –
113 114
115
116 117

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
  • RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
  • RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
  • RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
  • RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
  • RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.

Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.